The global triamcinolone acetonide ointment market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The growth of the market is attributed to the rising cases of topical inflammatory dermatoses and ulcerative lesions globally. According to National Eczema Association (NEA), in 202, approximately 31.6 million that is 10.1% people out of the total population of the US have some form of eczema. More than 9.6 million US children under the age of 18 have atopic dermatitis (AD). An estimated 16.5 million of the US adults have an AD that initially began at 2 years of age, with nearly 40% affected by moderate or severe disease.
(Get 15% Discount on Buying this Report)
A full report is available at : https://orionmarketreports.com/global-triamcinolone-acetonide-ointment/92789/
According to the American Academy of Dermatology (AAD), approximately 7.5 million people in the US have psoriasis. It occurs in all age groups but is primarily seen in adults, with the highest proportion between ages 45 and 65. Approximately 25-30% of people with psoriasis experience joint inflammation that produces symptoms of arthritis. The growing demand for the treatment of these infectious diseases is propelling the growth of the market. There is a surge in demand for topical corticosteroids such as triamcinolone acetonide.
Market Coverage
The market number available for – 2022-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Type
By Application
By Distribution Channel
Regions Covered-
- North America
- Europe
- Asia-Pacific
Rest of the World
Competitive Landscape– G&W laboratories Inc., Lannett Co. Inc., Perrigo Co. PLC, Taro Pharmaceutical Industries Ltd., Mylan NV, Lupin Inc. and Teva Pharmaceutical Industries Ltd. among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How are playersaddressing challenges to sustain growth?
- Where is the investment opportunity?
Global Triamcinolone Acetonide Ointment Market Report by Segment
By Type
- 025%
- 1%
By Application
- Dermatoses
- Ulcerative Lesions
- Others
By Distribution Channel
- Hospitals
- Drug Stores
- Others
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name : Orion Market Reports
Contact Person : Mr. Anurag Tiwari
Email : Info@orionmarketreports.com
Contact No : +91 780-304-0404
This release has been published on Global market Post
Global market Post is not responsible for any content included in this release.
